Cargando…

Emerging Roles of SIRT1 in Alcoholic Liver Disease

Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease worldwide with a wide spectrum of liver pathologies ranging from simple steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. It has been demonstrated that ALD is mediated in whole or in part by a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Ruixue, Wang, Ziming, Wu, Miaomiao, Wang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645991/ https://www.ncbi.nlm.nih.gov/pubmed/33162823 http://dx.doi.org/10.7150/ijbs.49535

Ejemplares similares

Emerging roles of SIRT1 in fatty liver diseases
por: Ding, Ren-Bo, et al.
Publicado: (2017)

Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)
por: Anggreini, Putri, et al.
Publicado: (2022)

Hepatocyte-specific deletion of cellular repressor of E1A-stimulated genes 1 exacerbates alcohol-induced liver injury by activating stress kinases
por: Wu, Miaomiao, et al.
Publicado: (2022)

SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease
por: Cho, Eun-Hee
Publicado: (2014)

SIRT1 and SIRT2: emerging targets in neurodegeneration
por: Donmez, Gizem, et al.
Publicado: (2013)

Myeloid cells in alcoholic liver diseases: Mechanism and prospect
por: Xu, Wentao, et al.
Publicado: (2022)

Role of SIRT3 in neurological diseases and rehabilitation training
por: Li, Yanlin, et al.
Publicado: (2022)

Novel Role of the SIRT1 in Endocrine and Metabolic Diseases
por: Lu, Chenxi, et al.
Publicado: (2023)

The Beneficial Roles of SIRT1 in Drug-Induced Liver Injury
por: Yan, Tingdong, et al.
Publicado: (2019)

Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis
por: Zhou, Ying, et al.
Publicado: (2022)

Emerging Roles of Calcium Signaling in the Development of Non-Alcoholic Fatty Liver Disease
por: Chen, Chien-Chih, et al.
Publicado: (2021)

Combined intake of blueberry juice and probiotics ameliorate mitochondrial dysfunction by activating SIRT1 in alcoholic fatty liver disease
por: Fan, Houmin, et al.
Publicado: (2021)

The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations
por: Li, Xuan, et al.
Publicado: (2020)

Emerging role of SIRT2 in non-small cell lung cancer
por: Zheng, Mengge, et al.
Publicado: (2021)

Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
por: Moghtadaie, Atie, et al.
Publicado: (2023)

Alcoholic Liver Disease: Role of Cytokines
por: Neuman, Manuela G., et al.
Publicado: (2015)

Hepatic SIRT3 Upregulation in Response to Chronic Alcohol Consumption Contributes to Alcoholic Liver Disease in Mice
por: Ma, Yue, et al.
Publicado: (2019)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases
por: Jiao, Fangzhou, et al.
Publicado: (2020)

Role of SIRT1 in Chemoresistant Leukemia
por: Fajardo-Orduña, Guadalupe Rosario, et al.
Publicado: (2023)

The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway
por: Zhu, Juanjuan, et al.
Publicado: (2016)

Roles of Gut Microbiota in Alcoholic Liver Disease
por: Zhang, Daya, et al.
Publicado: (2023)

Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
por: Torres, Jorge-Luis, et al.
Publicado: (2018)

11β-HSD1 Inhibitor Alleviates Non-Alcoholic Fatty Liver Disease by Activating the AMPK/SIRT1 Signaling Pathway
por: Chen, Ying, et al.
Publicado: (2022)

Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1
por: Gomes, Bruno Alexandre Quadros, et al.
Publicado: (2018)

As a Modulator, Multitasking Roles of SIRT1 in Respiratory Diseases
por: Zhou, Yunxin, et al.
Publicado: (2022)

The role of different SIRT1-mediated signaling pathways in toxic injury
por: Ren, Zhihua, et al.
Publicado: (2019)

SIRT1 Modulators in Experimentally Induced Liver Injury
por: Farghali, Hassan, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
por: Han, Eugene, et al.
Publicado: (2017)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)

Role of Adaptive Immunity in Alcoholic Liver Disease
por: Albano, Emanuele
Publicado: (2012)

Roles of the complement system in alcohol-induced liver disease
por: Zhou, Yi, et al.
Publicado: (2020)

Emerging Roles of SIRT3 in Cardiac Metabolism
por: Murugasamy, Krishnega, et al.
Publicado: (2022)

Alcoholic Liver Disease: Update on the Role of Dietary Fat
por: Kirpich, Irina A., et al.
Publicado: (2016)

Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
por: Hajduch, Eric, et al.
Publicado: (2021)

Role of Leptin in Non-Alcoholic Fatty Liver Disease
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

The Role of Non-Alcoholic Fatty Liver Disease in Infections
por: Krznarić, Juraj, et al.
Publicado: (2022)

The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease
por: Winarto, Jessica, et al.
Publicado: (2023)

Promotion of autophagosome–lysosome fusion via salvianolic acid A-mediated SIRT1 up-regulation ameliorates alcoholic liver disease
por: Shi, Xue, et al.
Publicado: (2018)

Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease
por: Wu, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j90utu8lelc523k4c2ff10uhid